In the first place, only some of the blood proteins that may be involved in coagulopathies have been explored here so that a number of other blood proteins targets such as complement proteins, platelet glycoprotein 1b, Rhesus blood factors, etc., need to be tested for cross-reactivity with SARS-CoV-2, adenovirus and bacterial antibodies. Here, VTN is linked to blood coagulation disease.